| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 10.572 | 44.365 | 10.415 | 19.918 | 45.124 | 79.656 | 85.018 | 93.010 |
| Total Income - EUR | - | - | 10.572 | 44.365 | 10.415 | 19.918 | 45.124 | 79.656 | 85.018 | 93.010 |
| Total Expenses - EUR | - | - | 691 | 13.439 | 21.632 | 20.765 | 18.496 | 29.537 | 34.083 | 34.846 |
| Gross Profit/Loss - EUR | - | - | 9.882 | 30.926 | -11.217 | -847 | 26.628 | 50.120 | 50.936 | 58.164 |
| Net Profit/Loss - EUR | - | - | 9.553 | 29.903 | -11.529 | -1.286 | 25.308 | 48.461 | 50.188 | 49.150 |
| Employees | - | - | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 1 |
Check the financial reports for the company - Pavelmed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 0 | 54.654 | 39.304 | 24.537 | 11.466 | 58.160 | 42.606 | 25.755 |
| Current Assets | - | - | 23.002 | 23.403 | 13.139 | 22.047 | 37.142 | 57.475 | 85.810 | 139.966 |
| Inventories | - | - | 0 | 0 | 316 | 310 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 6.027 | 22.902 | 12.360 | 21.594 | 36.953 | 42.018 | 22.069 | 27.286 |
| Cash | - | - | 16.976 | 501 | 462 | 142 | 189 | 15.457 | 13.200 | 62.422 |
| Shareholders Funds | - | - | 9.597 | 39.324 | 27.032 | 25.234 | 29.767 | 78.320 | 101.435 | 150.018 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 13.405 | 38.733 | 25.410 | 21.350 | 18.842 | 37.315 | 26.980 | 15.703 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Pavelmed Srl